Research Article
Three-Dimensional Multidetector CT for Anatomic Evaluation of Orbital Tumors
Table 1
Baseline patient demographic and clinical data.
| Patient number | Age/Sex | CT collimation (mm) | Tumor pathology | Tumor location | Treatment |
| 1 | 43/M | 2.5 mm | ACC | Lacrimal gland | Exenteration | 2 | 43/F | 2.5 mm | ACC | Lacrimal gland | Exenteration | 3* | 47/F | 1.25 mm | ACC | Lacrimal gland | Exenteration | 4 | 43/F | 5.0 mm | ACC | Lacrimal gland | Exenteration | 5 | 69/F | 1.25 mm | ACC | Lacrimal gland | Exenteration | 6 | 24/F | 1.25 mm | ACC | Lacrimal gland | Resection | 7 | 29/M | 1.25 mm | ACC | Lacrimal gland | Exenteration | 8 | 36/M | 1.25 mm | ACC | Lacrimal gland | Exenteration | 9 | 17/M | 1.25 mm | Carcinoma ex-pleomorphic adenoma | Lacrimal gland | Exenteration | 10 | 25/F | 1.25 mm | Pleomorphic adenoma | Lacrimal gland | Resection | 11 | 57/M | 1.25 mm | ACC | Lacrimal gland/sac | Exenteration | 12 | 53/F | 1.25 mm | Inverted papilloma | Lacrimal sac | Resection | 13 | 51/M | 1.25 mm | Synovial sarcoma | Intraconal | Exenteration | 14 | 56/M | 1.25 mm | Invasive basal cell carcinoma | Periorbital/infraorbital nerve | Chemoradiation | 15 | 80/F | 1.25 mm | Basaloid squamous carcinoma | Medial canthus | Exenteration | 16 | 67/F | 5 mm | Invasive squamous carcinoma | Medial canthus | Exenteration | 17 | 59/M | 2.5 mm | Neuroendocrine carcinoma | Intraconal | Exenteration | 18 | 51/M | 1.25 mm | Invasive squamous carcinoma | Medial orbit/sinonasal | Resection | 19 | 46/M | 1.25 mm | Neuroendocrine carcinoma | Medial orbit/sinonasal | Chemoradiation | 20 | 46/M | 1.25 mm | Pseudotumor** | Orbital apex | Steroids |
|
|
ACC: adenoid cystic carcinoma; NA: not applicable.
*No intravenous contrast.
**Responded to treatment with steroids.
|